Omada Health merges technology and medicine in the clinic to treat chronic diseases

October 5, 2016 Christoph Graener

When technology and medicine combine, organizations that merge deep technology, deep pharma and deep clinical work are bound to emerge. Leading the pack are companies like Omada, a digital health program for the chronic diseases that plague developed and developing countries. What makes Omada so unique though, is that it is one of the first companies of its kind to partner with the American Medical Association (AMA). By doing this, they can use evidence-generated products that can be built and commercialized with physicians. As the CEO explains in this interview, the real success of Omada is their unique ability to adhere to the company’s partner-forward strategy, a strategy they came to BioPharm America™ 2016 to discuss and grow.

 


Interviewer: Nicole Fisher – Founder and CEO, HHR Strategies, Inc.
Interviewee: Sean Duffy – Co-Founder and CEO, Omada Health

Previous Article
CureDuchenne: The Mom Filter scores three profitable exits, one FDA approval
CureDuchenne: The Mom Filter scores three profitable exits, one FDA approval

Debra Miller takes drug development very seriously when it has anything to do with Duchenne muscular dystro...

Next Article
Puerto Rico poised to tackle development of a HIV-AIDS vaccine
Puerto Rico poised to tackle development of a HIV-AIDS vaccine